Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+4.4%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$24.6B
AUM Growth
+$2.03B
(+9%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
5.09%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$168M |
| 2 |
Apple
AAPL
|
$71.3M |
| 3 |
Microsoft
MSFT
|
$57.4M |
| 4 |
HDFC Bank
HDB
|
$44.6M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
$40.5M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$83.3M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$81.2M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$43.3M |
| 4 |
Broadcom
AVGO
|
$42.7M |
| 5 |
Advanced Micro Devices
AMD
|
$37.7M |
Sector Composition
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 10.25% |
| 3 | Communication Services | 8.94% |
| 4 | Healthcare | 6.61% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
MeiraGTx Holdings
MGTX
$619M
| $16.2K | ﹤0.01% |
2,604
-195
| -7% | -$1.21K |
|
1452
Theravance Biopharma
TBPH
$703M
| $15.7K | ﹤0.01% |
1,639
-130
| -7% | -$1.25K |
|
1453
Alpha Teknova
TKNO
$233M
| $15.5K | ﹤0.01% |
+1,776
| New | +$15.5K |
|
1454
Sprott Uranium Miners ETF
URNM
$1.68B
| $15.5K | ﹤0.01% |
387
| – | – |
|
1455
IPG Photonics
IPGP
$3.56B
| $15.4K | ﹤0.01% |
210
-53
| -20% | -$3.89K |
|
|
THRD
1456
DELISTED
Third Harmonic Bio
THRD
| $15.4K | ﹤0.01% |
1,502
+16
| +1% | +$164 |
|
1457
Arcturus Therapeutics
ARCT
$485M
| $15.4K | ﹤0.01% |
903
-75
| -8% | -$1.28K |
|
1458
Allogene Therapeutics
ALLO
$255M
| $15.3K | ﹤0.01% |
6,987
-576
| -8% | -$1.26K |
|
1459
UroGen Pharma
URGN
$873M
| $15.1K | ﹤0.01% |
1,406
-117
| -8% | -$1.26K |
|
|
AUTL
1460
Autolus Therapeutics
AUTL
$389M
| $15K | ﹤0.01% |
6,655
-565
| -8% | -$1.28K |
|
1461
Esperion Therapeutics
ESPR
$540M
| $15K | ﹤0.01% |
+6,566
| New | +$15K |
|
1462
Zevra Therapeutics
ZVRA
$502M
| $14.9K | ﹤0.01% |
+1,779
| New | +$14.9K |
|
|
FPI
1463
Farmland Partners
FPI
$473M
| $14.8K | ﹤0.01% |
1,277
-499
| -28% | -$5.77K |
|
1464
HUTCHMED
HCM
$2.74B
| $14.8K | ﹤0.01% |
1,034
-88
| -8% | -$1.26K |
|
1465
Steven Madden
SHOO
$2.2B
| $14.7K | ﹤0.01% |
+347
| New | +$14.7K |
|
1466
MaxCyte
MXCT
$150M
| $14.5K | ﹤0.01% |
3,515
-286
| -8% | -$1.18K |
|
1467
OmniAb
OABI
$246M
| $14.5K | ﹤0.01% |
4,033
-241
| -6% | -$865 |
|
1468
Monte Rosa Therapeutics
GLUE
$305M
| $14.5K | ﹤0.01% |
+2,047
| New | +$14.5K |
|
|
CHCT
1469
Community Healthcare Trust
CHCT
$444M
| $14.4K | ﹤0.01% |
783
-292
| -27% | -$5.36K |
|
|
DDL
1470
Dingdong
DDL
$470M
| $14.3K | ﹤0.01% |
+3,986
| New | +$14.3K |
|
1471
Phibro Animal Health
PAHC
$1.6B
| $14.3K | ﹤0.01% |
678
-58
| -8% | -$1.22K |
|
|
BFS
1472
Saul Centers
BFS
$812M
| $14.2K | ﹤0.01% |
370
-142
| -28% | -$5.45K |
|
1473
SIGA Technologies
SIGA
$603M
| $14.1K | ﹤0.01% |
2,379
-202
| -8% | -$1.2K |
|
1474
Aura Biosciences
AURA
$403M
| $13.9K | ﹤0.01% |
+1,665
| New | +$13.9K |
|
1475
KalVista Pharmaceuticals
KALV
$796M
| $13.8K | ﹤0.01% |
1,623
+65
| +4% | +$554 |
|